CHI Advisors LLC
CIK
1791468
Location
New York, NY
Portfolio Value
Small
$143,727,549
Diversification
Moderately concentrated
Filing Date
Global Rank
#3,823
/ 6,900
▲ 1
· as of Sep 2023
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-27.7%
Period ended 2 years ago
Filed Nov 13, 2023 · 2y
15 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-18.6%
SPY
+76.0%
Annualised alpha
-27.3%
Max drawdown
−74.4%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
12 positions · as of Sep 30, 2023 · Δ vs Jun 30, 2023Top Position
38.0%
−1.7 pts
Top 5
83.3%
−5.5 pts
Top 10
97.7%
−2.3 pts
HHI
2,154
Moderately concentrated−283
Portfolio Trend
15 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2023| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $143,727,549 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reduced
3 positions
Sold Out
Positions the filer fully exited
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals, Inc. | 200,000 | $458,000 | |
| No positions match the current search. | ||||
12 positions ·
$143,727,549 total
· as of Sep 30, 2023
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| PLRX |
Pliant Therapeutics, Inc.
Healthcare
|
Reduced | 3,151,699 | $54,650,460 | 38.02% | |
| CGEM |
Cullinan Therapeutics, Inc.
Healthcare
|
Held | 3,414,189 | $30,898,410 | 21.50% | |
| LRMR |
Larimar Therapeutics, Inc.
Healthcare
|
Held | 3,414,468 | $13,487,148 | 9.38% | |
| KROS |
Keros Therapeutics, Inc.
Healthcare
|
Added | 407,633 | $12,995,340 | 9.04% | |
| RARE |
Ultragenyx Pharmaceutical Inc.
Healthcare
|
Added | 215,000 | $7,664,750 | 5.33% | |
| CMPX |
Compass Therapeutics, Inc.
Healthcare
|
Held | 2,829,712 | $5,574,532 | 3.88% | |
| MLYS |
Mineralys Therapeutics, Inc.
Healthcare
|
NEW | 568,379 | $5,405,284 | 3.76% | |
| MLTX |
MoonLake Immunotherapeutics
Healthcare
|
NEW | 60,000 | $3,420,000 | 2.38% | |
| OVID |
Ovid Therapeutics Inc.
Healthcare
|
Held | 864,822 | $3,320,916 | 2.31% | |
| SGMT |
Sagimet Biosciences Inc.
Healthcare
|
NEW | 348,842 | $3,069,809 | 2.14% | |
| BDTX |
Black Diamond Therapeutics, Inc.
Healthcare
|
Reduced | 720,000 | $2,066,400 | 1.44% | |
| IRON |
Disc Medicine, Inc.
Healthcare
|
Reduced | 25,000 | $1,174,500 | 0.82% |